Contemporary Treatment Strategies For Androgen Deprivation Therapy In Prostate Cancer VL

Hormone Therapy with GnRH Agonists in Men with Prostate Cancer and CV Risk – “The American Heart Association Guidance” - Matthew Smith

Details
Contemporary Treatment Strategies For Androgen Deprivation Therapy In Prostate Cancer Presentation: Hormone Therapy with GnRH Agonists in Men with Prostate Cancer and CV Risk – “The American Heart Association Guidance” 12-minute lecture. Independent Medical Education Initiative Supported by Myovant Sciences Biographies: Matthew R. Smith, MD, Ph.D., Professor of Medicine, Harvard Medical School, As...

Complications of Androgen Deprivation Therapy for Prostate Cancer - Charles Ryan

Details
Contemporary Treatment Strategies For Androgen Deprivation Therapy In Prostate Cancer - Lecture Presentation, Complications of Androgen Deprivation Therapy for Prostate Cancer - Charles J Ryan (12-minutes). Independent Medical Education Initiative Supported by Myovant Sciences Biographies: Charles J. Ryan, MD , The B.J. Kennedy Chair in Clinical Medical Oncology at the University of Minnesota and...

Cardiovascular Health of Men Treated with ADT for Prostate Cancer Discussion - Michael Cookson, Alicia Morgans, Matthew Smith & Charles Ryan

Details
Contemporary Treatment Strategies For Androgen Deprivation Therapy In Prostate Cancer Bridging the Lectures on "Hormone Therapy with GnRH Agonists in Men with Prostate Cancer and CV Risk – The American Heart Association Guidance” and "Complications of Androgen Deprivation Therapy for Prostate Cancer " This discussion with Alicia Morgans and Michael Cookson with Matthew Smith and Charles Ryan. 20-m...

Considerations of Bone Health in Men Treated for Prostate Cancer - Fred Saad

Details
Contemporary Treatment Strategies For Androgen Deprivation Therapy In Prostate Cancer. Module 3: Considerations of Bone Health in Men Treated for Prostate Cancer. Independent Medical Education Initiative Supported by Myovant Sciences Biographies: Fred Saad, MD, FRCS, Professor and Chief of Urology, Director of GU Oncology, Raymond Garneau Chair in Prostate Cancer, University of Montreal Hospital C...

Discussion - Considerations of Bone Health in Men Treated for Prostate Cancer - Michael Cookson, Alicia Morgans & Fred Saad

Details
Contemporary Treatment Strategies For Androgen Deprivation Therapy In Prostate Cancer, - Discussion: Considerations of Bone Health in Men Treated for Prostate Cancer. - 20 minutes Independent Medical Education Initiative Supported by Myovant Sciences Biographies: Fred Saad, MD, FRCS, Professor and Chief of Urology, Director of GU Oncology, Raymond Garneau Chair in Prostate Cancer, University of Mo...

Androgen Deprivation With Oral Relugolix vs Leuprolide in Advanced Prostate Cancer: HERO Trial- Neal Shore

Details
Contemporary Treatment Strategies For Androgen Deprivation Therapy In Prostate Cancer Lecture Presentation - Androgen Deprivation With Oral Relugolix vs Leuprolide in Advanced Prostate Cancer: HERO Trial - Neal Shore (12-minute lecture) Independent Medical Education Initiative Supported by Myovant Sciences Biographies: Neal Shore, MD, FACS , is the Medical Director of the Carolina Urologic Researc...

Androgen Deprivation With Oral Relugolix vs Leuprolide in Advanced Prostate Cancer: HERO Trial Discussion - Michael Cookson - Alicia Morgans & Neal Shore

Details
Contemporary Treatment Strategies For Androgen Deprivation Therapy In Prostate Cancer Androgen Deprivation With Oral Relugolix vs Leuprolide in Advanced Prostate Cancer: HERO Trial - Moderated Discussion (20-minutes). Independent Medical Education Initiative Supported by Myovant Sciences Biographies: Neal Shore, MD, FACS , is the Medical Director of the Carolina Urologic Research Center. He practi...

Optimizing the Use of Androgen Deprivation Therapy in Men with Intermediate-Risk Prostate Cancer Presentation - Felix Feng

Details
Contemporary Treatment Strategies For Androgen Deprivation Therapy In Prostate Cancer Presentation - Optimizing the Use of Androgen Deprivation Therapy in Men with Intermediate-Risk Prostate Cancer Felix Feng. (12 minutes). Independent Medical Education Initiative Supported by Myovant Sciences Biographies: Felix Y. Feng MD, Professor of Radiation Oncology; Urology; and Medicine, Vice Chair for Fac...

Discussion Optimizing the Use of Androgen Deprivation Therapy in Men with Intermediate-Risk Prostate Cancer - Michael Cookson, Alicia Morgans & Felix Feng

Details
Contemporary Treatment Strategies For Androgen Deprivation Therapy In Prostate Cancer Discussion - Optimizing the Use of Androgen Deprivation Therapy in Men with Intermediate-Risk Prostate Cancer: 13 minutes. Independent Medical Education Initiative Supported by Myovant Sciences Biographies: Michael Cookson, MD, MMHC, Professor, and Chairman, Department of Urology, University of Oklahoma Health Sc...

The Role of ADT in Men Being Treated with Radiation Therapy - Daniel Spratt

Details
Contemporary Treatment Strategies For Androgen Deprivation Therapy In Prostate Cancer Presentation. The Role of ADT in Men Being Treated with Radiation Therapy Daniel Spratt (12-minutes) Independent Medical Education Initiative Supported by Myovant Sciences Biographies: Daniel Spratt, MD, Tenured Full Professor of Radiation Oncology and a leader in Prostate and Spine malignancies. Chief of the Gen...
email news signup